267 related articles for article (PubMed ID: 34450051)
1. Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation: A population-based analysis.
Dawwas GK; Barnes GD; Dietrich E; Cuker A; Leonard CE; Genuardi MV; Lewis JD
Am Heart J; 2021 Dec; 242():71-81. PubMed ID: 34450051
[TBL] [Abstract][Full Text] [Related]
2. Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.
Douros A; Renoux C; Yin H; Filion KB; Suissa S; Azoulay L
Am J Med; 2019 Feb; 132(2):191-199.e12. PubMed ID: 30691551
[TBL] [Abstract][Full Text] [Related]
3. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA
Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654
[TBL] [Abstract][Full Text] [Related]
4. Direct Oral Anticoagulants Would Be Best Choice for Atrial Fibrillation Patients After Coronary Stenting: Retrospective Study in a Japanese Population.
Koiwaya H; Watanabe N; Kuriyama N; Shibata Y
Kurume Med J; 2023 Jul; 68(2):97-106. PubMed ID: 37100602
[TBL] [Abstract][Full Text] [Related]
5. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
[No Abstract] [Full Text] [Related]
6. Direct oral anticoagulant and antiplatelet combination therapy: Hemorrhagic events in coronary artery stent recipients.
Bekelis K; Chang CH; Malenka D; Morden NE
J Clin Neurosci; 2018 Apr; 50():24-29. PubMed ID: 29396074
[TBL] [Abstract][Full Text] [Related]
7. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation.
Mehta HB; An H; Ardeshirrouhanifard S; Raji MA; Alexander GC; Segal JB
Circ Cardiovasc Qual Outcomes; 2022 Dec; 15(12):e008951. PubMed ID: 36453260
[TBL] [Abstract][Full Text] [Related]
10. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
11. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
Sindet-Pedersen C; Lamberts M; Staerk L; Nissen Bonde A; Berger JS; Pallisgaard JL; Lock Hansen M; Torp-Pedersen C; Gislason GH; Olesen JB
J Am Coll Cardiol; 2018 Oct; 72(15):1790-1800. PubMed ID: 30286922
[TBL] [Abstract][Full Text] [Related]
12. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
[TBL] [Abstract][Full Text] [Related]
13. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
14. Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation.
Yoo SY; Kim E; Nam GB; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Choi J
Korean J Intern Med; 2022 May; 37(3):555-566. PubMed ID: 35078306
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
[TBL] [Abstract][Full Text] [Related]
16. Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study.
Lee HF; Chan YH; Li PR; Liu JR; Chao TF; Wu LS; Chang SH; Yeh YH; Kuo CT; See LC; Lip GYH
Can J Cardiol; 2021 Jan; 37(1):113-121. PubMed ID: 32492401
[TBL] [Abstract][Full Text] [Related]
17. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.
RAF and RENO-EXTEND Investigators*
Eur Stroke J; 2023 Sep; 8(3):722-730. PubMed ID: 37458099
[TBL] [Abstract][Full Text] [Related]
18. Advances in Antiplatelet and Anticoagulant Therapies for NSTE-ACS.
Badjatiya A; Rao SV
Curr Cardiol Rep; 2019 Jan; 21(1):3. PubMed ID: 30637536
[TBL] [Abstract][Full Text] [Related]
19. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
[TBL] [Abstract][Full Text] [Related]
20. Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study.
Li X; Pathadka S; Man KKC; Ng VWS; Siu CW; Wong ICK; Chan EW; Lau WCY
Drug Saf; 2020 Oct; 43(10):1023-1033. PubMed ID: 32557348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
